Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Tadalafil may help prevent erectile dysfunction (ED) in patients with prostate
cancer that has been treated with radiation therapy. It is not yet known whether tadalafil is
more effective than a placebo in preventing erectile dysfunction.
PURPOSE: This randomized phase III trial is studying tadalafil to see how well it works
compared with a placebo in preventing erectile dysfunction in patients with prostate cancer
treated with radiation therapy.